요관경 : 세계 시장 인사이트, 경쟁 환경 및 시장 예측(2030년)

Ureteroscope Market By Product Type (Flexible Ureteroscope [Digital Ureteroscope and Fiber Optic Ureteroscope], Semi-Rigid Ureteroscope), By Channel Type (Dual Channel and Single Channel), By Usability (Single-Use and Reusable), By Application (Urolithiasis, Urothelium Cancer, Urinary Strictures), By End-User (Hospitals, Ambulatory Surgical Centers, and Others), By Geography, is expected to grow at a constant CAGR forecast till 2030 due to the growing prevalence of urolithiasis among the population and technological advancement in the product portfolio.

The global ureteroscope market was valued at USD 0.90 billion in 2023, growing at a CAGR of 5.49% during the forecast period from 2024 to 2030, to reach USD 1.24 billion by 2030. The rise in demand for ureteroscope can be due to the growing prevalence of urolithiasis or nephrolithiasis accompanied by the rising burden of obesity which is a risk factor for development of kidney stones. In addition, sedentary lifestyle, innovation in product design, and new product launches among others are the factors responsible for the global market growth of ureteroscope.

Ureteroscope Market Dynamics:

Ureteroscope is gaining momentum in recent years owing to the rising prevalence of urolithiasis across the globe. According to the European Association of Urology 2019, the prevalence rates for urinary stones vary from 1% to 20%, and in the countries with a high standard of life such as Canada, Sweden, or the US, renal stones prevalence is significantly high (>10%).

Moreover, a rise in sedentary lifestyle such as excessive consumption of alcohol, less consumption of water could also lead to the development of kidney stones. In addition, the growing burden of obesity among the population, a high-risk factor for the development of renal calculi, due to sedentary lifestyles such as poor dietary habits and lack of physical activities could also contribute to the ureteroscope market growth. As per the World Health Organization (WHO) 2022 data, there was around 650 million obese population worldwide in the year 2016. Also, according to various studies (one of them being "Obesity and Its Impact on Kidney Stone Formation" by Poore W. et al., published in the NCBI in the year 2020) obese people develop more uric acid stones and calcium oxalate stones.

Thus, the aforementioned factors are anticipated to augment the global ureteroscope market growth.

However, certain factors such as the limited availability of a skilled workforce to utilise the device in medical setup and the high cost of ureteroscope devices are expected to pose a challenge to the ureteroscope market growth.

Ureteroscope Market Segment Analysis:

Ureteroscope Market Product Type (Flexible Ureteroscope [Digital Ureteroscope and Fiber Optic Ureteroscope], Semi-Rigid Ureteroscope), By Channel Type (Dual Channel and Single Channel), By Usability (Single-Use and Reusable), By Application (Urolithiasis, Ureter Transitional Cell Cancer, Urinary Strictures), By End User (Hospitals, Ambulatory Surgical Centers and Others), and By Geography (North America, Europe, Asia-Pacific, and Rest of the World).

In the Ureteroscope product segment, the flexible ureteroscope is anticipated to hold the largest market share during the forecasted period. This is due to the wide use of the flexible ureteroscope for the treatment of various kidney and ureter stones. Also, flexible ureteroscopy is a latest generation of device when compared to semi rigid ureteroscopy and thus they causes minimum pain and discomfort to the patient with low chances of injury. The advantages of flexible ureteroscopy over semi-rigid ureteroscopy will shift the demand of patients towards flexible ureteroscopy thereby increasing the market for flexible ureteroscope. Moreover, increase in flexible ureteroscopy in hospitals is also a factor driving the market for flexible ureteroscope. For instance, flexible ureteroscope are widely used along with laser lithotripsy in nearly all hospitals by the urologists for better management of urolithiasis with high success rate and low complication rate. Moreover, retrograde flexible ureteroscopy (RFU) has high sensitivity for the diagnosis of urinary tract urothelial carcinomas.

Thus, the above-mentioned factors are expected to drive the flexible ureteroscope market.

North America is expected to dominate the overall Ureteroscope Market:

Among all the regions, North America is expected to dominate the overall ureteroscope market. This domination is owing to the favourable reimbursement scenario, advanced healthcare infrastructure, and well-versed guidelines for the surgical and medical management of the upper tract stone disease in the region is projected to boost the ureteroscope market.

Further, in the United States the rising cases of upper tract urothelial carcinoma (UTUC), is also the reason for increase in usage of ureteroscope. For instance, as per the Centers for Disease Control and Prevention (CDC) 2020 data, approximately 17,500 women and 56,000 men suffer from bladder cancer in the US. Moreover, according to the Canadian cancer society 2020 data, there were around 12,200 Canadians suffered from bladder cancer in the year 2020.

In addition, the launch of new products in the region is likely to propel the market for ureteroscope in the region. For instance, in 2019, Dornier Medtech launched and announced the immediate availability of its new AXIS single-use digital flexible ureteroscope in the US. Thus, these factors are projected to contribute to the ureteroscope market during the forecasted period.

Additionally, the Asia-pacific region has future potential for the ureteroscope market. This is because of the rising number of kidney and bladder cancer in the region. Also, the growing cases of urolithiasis are factors expected to promote the growth of ureteroscope in the region. For instance, as per the GLOBOCAN 2022 data, there were approximately 21,096 and 16,861 cases of bladder and kidney respectively in India in the year 2020. Moreover, improving healthcare infrastructure, growing disposable income in the region could also boost the ureteroscope market.

Ureteroscope Market Key Players:

Some of the key market players operating in the Ureteroscope market include Olympus, Stryker, Boston Scientific Corporation, Richard Wolf GmbH, KARL STORZ, ELMED Medical Systems, PENTAX Medical, OPCOM, Dornier Medtech, Maxer Endoscopy GmbH, Vimex Sp. z o. o., AED.MD, NeoScope Inc., Advin Health Care, OTU Medical., Clarion Medical Technologies., Zhuhai Mindhao Medical Technology Co., Ltd., Innovex Medical Co., Ltd., Biorad Medisys Pvt Ltd., Shanghai SeeGen Photoelectric Technology Co., Ltd., and others.

Recent Developmental Activities in the Ureteroscope Market:

In August 2020, Olympus Winter & Ibe GmbH received the US FDA approval for OES Elite Ureteroscopes and Accessories under regulatory class II for endoscopic observation and therapy in the ureters, urethra, and urinary bladder.

Key Takeaways from the Ureteroscope Market Report Study

Market size analysis for current market size (2023), and market forecast for 5 years (2024-2030)

The effect of the COVID-19 pandemic on this market is significant. To capture and analyse suitable indicators, our experts are closely watching the Ureteroscope market.

Top key product/services/technology developments, merger, acquisition, partnership, joint venture happened for last 3 years

Key companies dominating the Global Ureteroscope Market.

Various opportunities available for the other competitor in the Ureteroscope Market space.

What are the top-performing segments in 2023? How these segments will perform in 2030?

Which are the top-performing regions and countries in the current market scenario?

Which are the regions and countries where companies should have concentrated on opportunities for Ureteroscope market growth in the coming future?

Target Audience Who Can Be Benefited from the Ureteroscope Market Report Study

Ureteroscope providers

Research organizations and consulting companies

Ureteroscope-related organization, association, forum, and other alliances

Government and corporate offices

Start-up companies, venture capitalists, and private equity firms

Distributors and Traders in Ureteroscope

Various End-users who want to know more about the Ureteroscope Market and latest technological developments in the Ureteroscope market.

Frequently Asked Questions for the Ureteroscope Market:

1. What is Ureteroscope?

Ureteroscope is a small flexible telescope that is inserted into the bladder and ureter to diagnose and treat a variety of problems associated with the urinary tract.

2. What is the market for Global Ureteroscope?

The global ureteroscope market was valued at USD 0.90 billion in 2023, growing at a CAGR of 5.49% during the forecast period from 2024 to 2030, to reach USD 1.24 billion by 2030.

3. What are the drivers for the Global Ureteroscope?

The major factors driving the demand for Ureteroscope are the rising cases of urolithiasis, increase in demand for minimally invasive procedures for kidney stone management, rising sedentary lifestyle, among others. In addition, new product launch and technological advancement in the ureteroscope product portfolio is also expected to augment the market.

4. What are the key players operating in Global Ureteroscope?

Some of the key market players operating in the Ureteroscope market include Olympus, Stryker, Boston Scientific Corporation, Richard Wolf GmbH, KARL STORZ, ELMED Medical Systems, PENTAX Medical, OPCOM, Dornier Medtech, Maxer Endoscopy GmbH, Vimex Sp. z o. o., AED.MD, NeoScope Inc., Advin Health Care, OTU Medical., Clarion Medical Technologies., Zhuhai Mindhao Medical Technology Co., Ltd., Innovex Medical Co., Ltd., Biorad Medisys Pvt Ltd., Shanghai SeeGen Photoelectric Technology Co., Ltd., and others.

5. Which region has the highest share in the Ureteroscope market?

Among all the regions, North America is expected to dominate the overall ureteroscope market during the forecasted period, 2024-2030. This domination is owing to the favorable reimbursement scenario, advanced healthcare infrastructure, and well-versed guidelines for the surgical and medical management of the upper tract stone disease in the region is projected to boost the ureteroscope market.

Table of Contents

1. Ureteroscope Market Report Introduction

2. Ureteroscope Market Executive summary

• 2.1. Scope of the Study
• 2.2. Market at Glance
• 2.3. Competitive Assessment
• 2.4. Financial Benchmarking

3. Regulatory and Patent Analysis

• 3.1. The United States
• 3.2. Europe
  • 3.2.1. Germany
  • 3.2.2. France
  • 3.2.3. Italy
  • 3.2.4. Spain
  • 3.2.5. The U.K.
• 3.3. Japan

4. Ureteroscope Market Key factors analysis

• 4.1. Ureteroscope Market Drivers
  • 4.1.1. Growing prevalence of urolithiasis or nephrolithiasis
  • 4.1.2. Innovation in product design
  • 4.1.3. Increasing Product launches
  • 4.1.4. Rising cases of upper tract urothelial carcinoma
• 4.2. Ureteroscope Market Restraints and Challenges
  • 4.2.1. High cost of the ureteroscope
  • 4.2.2. Limited availability of skilled workforce
• 4.3. Ureteroscope Market Opportunities
  • 4.3.1. Growth opportunities in low-income regions
  • 4.3.2. Growing opportunities in single-use ureteroscope

5. Ureteroscope Porter's Five Forces Analysis

• 5.1. Bargaining Power of Suppliers
• 5.2. Bargaining Power of Consumers
• 5.3. Threat of New Entrants
• 5.4. Threat of Substitutes 5.5 Competitive Rivalry

6. COVID-19 Impact Analysis on Ureteroscope Market

7. Ureteroscope Market layout

• 7.1. By Product Type
  • 7.1.1. Flexible Ureteroscope
    • 7.1.1.1. Digital Ureteroscope
    • 7.1.1.2. Fiber optic Ureteroscope
  • 7.1.2. Semi-rigid Ureteroscope
• 7.2. By Channel Type
  • 7.2.1. Dual Channel
  • 7.2.2. Single Channel
• 7.3. By Usability
  • 7.3.1. Reusable
  • 7.3.2. Single-use
• 7.4. By Application
  • 7.4.1. Urolithiasis
  • 7.4.2. Ureter Transitional Cell cancer
  • 7.4.3. Urinary Strictures
  • 7.4.4. Others
• 7.5. By End-user
  • 7.5.1. Hospitals
  • 7.5.2. Ambulatory Surgical Centers
  • 7.5.3. Others
• 7.6. By Geography
  • 7.6.1. North America
    • 7.6.1.1. North America Ureteroscope Market, by Product Type
    • 7.6.1.2. North America Ureteroscope Market, by Channel Type
    • 7.6.1.3. North America Ureteroscope Market, by Usability
    • 7.6.1.4. North America Ureteroscope Market, by Application
    • 7.6.1.5. North America Ureteroscope Market, by End User
    • 7.6.1.6. North America Ureteroscope Market, by Country
    • 7.6.1.6.1. United States
    • 7.6.1.6.2. Canada
    • 7.6.1.6.3. Mexico
  • 7.6.2. Europe
    • 7.6.2.1. Europe Ureteroscope Market, by Product Type
    • 7.6.2.2. Europe Ureteroscope Market, by Channel Type
    • 7.6.2.3. Europe Ureteroscope Market, by Usability
    • 7.6.2.4. Europe Ureteroscope Market, by Application
    • 7.6.2.5. Europe Ureteroscope Market, by End User
    • 7.6.2.6. Europe Ureteroscope Market, by Country
    • 7.6.2.6.1. France
    • 7.6.2.6.2. Germany
    • 7.6.2.6.3. United Kingdom
    • 7.6.2.6.4. Italy
    • 7.6.2.6.5. Spain
    • 7.6.2.6.6. Russia
    • 7.6.2.6.7. Rest of Europe
  • 7.6.3. Asia-Pacific
    • 7.6.3.1. Asia-Pacific Ureteroscope Market, by Product Type
    • 7.6.3.2. Asia-Pacific Ureteroscope Market, by Channel Type
    • 7.6.3.3. Asia-Pacific Ureteroscope Market, by Usability
    • 7.6.3.4. Asia-Pacific Ureteroscope Market, by Application
    • 7.6.3.5. Asia-Pacific Ureteroscope Market, by End User
    • 7.6.3.6. Asia-Pacific Ureteroscope Market, by Country
    • 7.6.3.6.1. China
    • 7.6.3.6.2. Japan
    • 7.6.3.6.3. India
    • 7.6.3.6.4. Australia
    • 7.6.3.6.5. South Korea
    • 7.6.3.6.6. Rest of Asia Pacific
  • 7.6.4. Rest of the World (RoW)
    • 7.6.4.1. RoW Ureteroscope Market, by Product Type
    • 7.6.4.2. RoW Ureteroscope Market, by Channel Type
    • 7.6.4.3. RoW Ureteroscope Market, by Usability
    • 7.6.4.4. RoW Ureteroscope Market, by Application
    • 7.6.4.5. RoW Ureteroscope Market, by End User
    • 7.6.4.6. RoW Ureteroscope Market, by Region
    • 7.6.4.6.1. Middle East
    • 7.6.4.6.2. Africa
    • 7.6.4.6.3. South America

8. Ureteroscope Global Company Share Analysis - Key 3-5 Companies

9. Ureteroscope Company and Product Profiles

• 9.1. Olympus
  • 9.1.1. Company Overview
  • 9.1.2. Company Snapshot
  • 9.1.3. Financial Overview
  • 9.1.4. Product Listing
  • 9.1.5. Entropy
• 9.2. Stryker
  • 9.2.1. Company Overview
  • 9.2.2. Company Snapshot
  • 9.2.3. Financial Overview
  • 9.2.4. Product Listing
  • 9.2.5. Entropy
• 9.3. Boston Scientific Corporation
  • 9.3.1. Company Overview
  • 9.3.2. Company Snapshot
  • 9.3.3. Financial Overview
  • 9.3.4. Product Listing
  • 9.3.5. Entropy
• 9.4. Richard Wolf GmbH
  • 9.4.1. Company Overview
  • 9.4.2. Company Snapshot
  • 9.4.3. Financial Overview
  • 9.4.4. Product Listing
  • 9.4.5. Entropy
• 9.5. KARL STORZ
  • 9.5.1. Company Overview
  • 9.5.2. Company Snapshot
  • 9.5.3. Financial Overview
  • 9.5.4. Product Listing
  • 9.5.5. Entropy
• 9.6. ELMED Medical Systems
  • 9.6.1. Company Overview
  • 9.6.2. Company Snapshot
  • 9.6.3. Financial Overview
  • 9.6.4. Product Listing
  • 9.6.5. Entropy
• 9.7. PENTAX Medical
  • 9.7.1. Company Overview
  • 9.7.2. Company Snapshot
  • 9.7.3. Financial Overview
  • 9.7.4. Product Listing
  • 9.7.5. Entropy
• 9.8. OPCOM
  • 9.8.1. Company Overview
  • 9.8.2. Company Snapshot
  • 9.8.3. Financial Overview
  • 9.8.4. Product Listing
  • 9.8.5. Entropy
• 9.9. Dornier Medtech
  • 9.9.1. Company Overview
  • 9.9.2. Company Snapshot
  • 9.9.3. Financial Overview
  • 9.9.4. Product Listing
  • 9.9.5. Entropy
• 9.10. Maxer Endoscopy GmbH
  • 9.10.1. Company Overview
  • 9.10.2. Company Snapshot
  • 9.10.3. Financial Overview
  • 9.10.4. Product Listing
  • 9.10.5. Entropy
• 9.11. Vimex Sp. z o. o.
  • 9.11.1. Company Overview
  • 9.11.2. Company Snapshot
  • 9.11.3. Financial Overview
  • 9.11.4. Product Listing
  • 9.11.5. Entropy
• 9.12. AED.MD
  • 9.12.1. Company Overview
  • 9.12.2. Company Snapshot
  • 9.12.3. Financial Overview
  • 9.12.4. Product Listing
  • 9.12.5. Entropy
• 9.13. NeoScope Inc.
  • 9.13.1. Company Overview
  • 9.13.2. Company Snapshot
  • 9.13.3. Financial Overview
  • 9.13.4. Product Listing
  • 9.13.5. Entropy
• 9.14. Biorad Medisys Pvt Ltd.
  • 9.14.1. Company Overview
  • 9.14.2. Company Snapshot
  • 9.14.3. Financial Overview
  • 9.14.4. Product Listing
  • 9.14.5. Entropy
• 9.15. Advin Health Care
  • 9.15.1. Company Overview
  • 9.15.2. Company Snapshot
  • 9.15.3. Financial Overview
  • 9.15.4. Product Listing
  • 9.15.5. Entropy
• 9.16. OTU Medical
  • 9.16.1. Company Overview
  • 9.16.2. Company Snapshot
  • 9.16.3. Financial Overview
  • 9.16.4. Product Listing
  • 9.16.5. Entropy
• 9.17. Clarion Medical Technologies
  • 9.17.1. Company Overview
  • 9.17.2. Company Snapshot
  • 9.17.3. Financial Overview
  • 9.17.4. Product Listing
  • 9.17.5. Entropy
• 9.18. Zhuhai Mindhao Medical Technology Co., Ltd
  • 9.18.1. Company Overview
  • 9.18.2. Company Snapshot
  • 9.18.3. Financial Overview
  • 9.18.4. Product Listing
  • 9.18.5. Entropy
• 9.19. Innovex Medical Co., Ltd.
  • 9.19.1. Company Overview
  • 9.19.2. Company Snapshot
  • 9.19.3. Financial Overview
  • 9.19.4. Product Listing
  • 9.19.5. Entropy
• 9.20. Shanghai SeeGen Photoelectric Technology Co., Ltd.
  • 9.20.1. Company Overview
  • 9.20.2. Company Snapshot
  • 9.20.3. Financial Overview
  • 9.20.4. Product Listing
  • 9.20.5. Entropy

10. Project Approach

• 10.1. Secondary Sources
• 10.2. Primary Sources
• 10.3. Data Triangulation
• 10.4. Key Expert Opinions

11. KOL Views

12. DelveInsight Capabilities

13. Disclaimer

14. About DelveInsight